Evidence map›Paper›PMID 24231406›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2014

The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.

Kyle D Fugit, Bradley D Anderson

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mitochondrial membrane potential.Analytical biochemistry · 2018
    Review
  8. Stimuli-responsive liposomes for drug delivery.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2017
    Review
  9. Article
  10. Article
  11. Article
  12. Insights into accelerated liposomal release of topotecan in plasma monitored by a non-invasive fluorescence spectroscopic method.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kyle D FugitDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40506, USA.
Bradley D AndersonDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40506, USA. Electronic address: bande2@uky.edu.
University of Kentucky · US

Funding

The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)R25CA153954 · NCI · UNIVERSITY OF KENTUCKY · PI ANDERSON, BRADLEY D, EVERS, BERNARD MARK · 2010 to 2014
$1.6M
NCI NIH HHS R25 CA153954NCI NIH HHS R25CA153954
6 · The paper itself

Abstract

The use of liposomal delivery systems for the treatment of cancer has been extensively researched because of their passive targeting to the vasculature of solid tumors. While their potential to provide prolonged retention and high drug encapsulation is desirable for anticancer agents, a mechanistic understanding is required to optimize and design liposomal drug delivery systems capable of controllable release tailored to tumor type and patient. Topotecan (TPT) is a topoisomerase I inhibitor that undergoes reversible, pH-sensitive ring-opening hydrolysis. TPT may benefit from liposomal formulation using active loading strategies to generate low intravesicular pH to prolong drug retention and increase drug encapsulation. This paper develops a mathematical model to describe TPT's permeability as a function of pH by accounting for the drug's ionization state, membrane binding, and ring-opening interconversion kinetics. Studies were conducted to determine the acid dissociation constant of TPT's phenolic -OH and interconversion kinetics between TPT's lactone and carboxylate forms. Using the constants determined from these studies and release studies conducted at varying pH, permeability coefficients and membrane binding constants for each species of TPT were determined. Based on this model, three permeable species were observed. Interestingly, the two most permeable species were zwitterionic forms of TPT, and the permeability of the lactone zwitterion was comparable to that of the neutral form of another camptothecin analogue. Furthermore, release was affected by based-catalyzed interconversion kinetics between TPT's lactone and carboxylate forms. At neutral pH, release was rate-limited by formation of the TPT lactone from the ring-opened carboxylate form. Based on these findings, the developed model describing liposomal release of TPT may be used in the future to evaluate and optimize loading and subsequent release of liposomal TPT formulations utilizing active loading strategies.

Indexed as

Models, BiologicalHydrogen-Ion ConcentrationHydrolysisKineticsLiposomesMembranes, ArtificialPhosphatidylcholinesPhosphatidylethanolaminesPolyethylene GlycolsTopoisomerase I InhibitorsTopotecan1,2-distearoyllecithin1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)LiposomesMembranes, ArtificialPhosphatidylcholinesPhosphatidylethanolaminesPolyethylene GlycolsTopoisomerase I InhibitorsTopotecanKineticsLiposomesMembrane bindingNanotechnologyPermeabilityTopotecan

Identifiers

PMID24231406
PMCPMC4104781
OpenAlexW2016767438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.